Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081)

Clinical trial NCT00978029 · COMPLETED

Trial details

NCT number: NCT00978029
Sponsor: ALK-Abelló A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rhinoconjunctivitis Rhinitis Conjunctivitis Allergy

Start date: 2009-11-01
Primary completion: 2010-02-01
Enrollment: 203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.